Navigation Links
Abbott's XIENCE V(R) Continues to Outperform TAXUS With Sustained Clinical Advantages and Impressive Long-Term Safety Results in SPIRIT III Trial
Date:9/21/2009

uticals and Medical Devices Agency.

Abbott also supplies a private-label version of XIENCE V to Boston Scientific called the PROMUS((R)) Everolimus-Eluting Coronary Stent System. PROMUS is designed and manufactured by Abbott and supplied to Boston Scientific as part of a distribution agreement between the two companies.

Everolimus, developed by Novartis Pharma AG, is a proliferation signal inhibitor, or mTOR inhibitor, licensed to Abbott by Novartis for use on its drug eluting stents. Everolimus has been shown to inhibit in-stent neointimal growth in the coronary vessels following stent implantation, due to its antiproliferative properties.

XIENCE V is indicated for improving coronary luminal diameter in patients with symptomatic heart disease due to de novo native coronary artery lesions (lesions less than or equal to 28 mm) with reference vessel diameters of 2.5 mm to 4.25 mm. Additional information about XIENCE V, including important safety information, is available online at www.xiencev.com or www.abbottvascular.com/en_US/content/document/eIFU_XienceV.pdf.

About Abbott Vascular

Abbott Vascular, a division of Abbott, is one of the world's leading vascular care businesses. Abbott Vascular is uniquely focused on advancing the treatment of vascular disease and improving patient care by combining the latest medical device innovations with world-class pharmaceuticals, investing in research and development, and advancing medicine through training and education. Headquartered in Northern California, Abbott Vascular offers a comprehensive portfolio of vessel closure, endovascular and coronary products.

About Abbott

Abbott is a glo
'/>"/>

SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Abbotts Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years
2. Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent
3. Abbotts XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years
4. XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years
5. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
6. Abbotts XIENCE(TM) V Drug Eluting Stent Demonstrates Consistent and Positive Clinical Outcomes Out to Two Years
7. SPIRIT II Explores Long-Term Performance of XIENCE V Stent
8. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
9. 18 month Follow-up Data on Phase III Study of Pixantrone in Late Stage Relapsed or Refractory, Aggressive Non-Hodgkins Lymphoma Continues to Demonstrate Significant Improvement in Complete Remission and Progression Free Survival Over Standard Chemotherap
10. Clinical Genomics Continues Progress in Developing Biomarker Portfolio for Colorectal Cancer Testing
11. Delcath Continues Expansion of Clinical Trial Centers Offering PHP(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... BRUNSWICK, N.J. , May 7, 2015 ... a first-of-its-kind partnership that enlists a third party to ... Johnson & Johnson (Janssen) for compassionate use ... as a pilot program focused on a single Janssen ... that will be applicable more broadly across Johnson & ...
(Date:5/6/2015)... May 6, 2015  Zimmer Holdings, Inc. (NYSE and SIX: ... it will be presenting at the Bank of America Merrill ... in Las Vegas, Nevada on Wednesday, ... A live webcast of the presentation can be accessed via ... will be archived for replay following the conference. ...
(Date:5/6/2015)... 2015  The fairness of the proposed acquisition of ... Pharmaceuticals, Inc. ("Alexion") is being investigated by WeissLaw LLP, ... possible breaches of fiduciary duty and other violations of ... agreeing to sell the Company to Alexion.  On May ... Alexion to acquire GEVA in a transaction valued at ...
Breaking Medicine Technology:Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines 2Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines 3Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines 4Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines 5WeissLaw LLP Investigates the Synageva Biopharma Corp. Acquisition 2
... Dec. 9, 2011 /PRNewswire-iReach/ -- Novel Health ... the publication of  2010-2011 market trends study called ,What,s ... The published article is an analysis of sales, pricing, ... specialty biologic products. This study highlights several emerging trends ...
... FRAMINGHAM, Mass. and SYDNEY, Dec. 9, 2011 HeartWare ... HIN), a leading innovator of less invasive, miniaturized circulatory ... heart failure, today announced that CEO Doug Godshall is ... Conference at 10:50 a.m. EST on Wednesday, December 14, ...
Cached Medicine Technology:Biotech Market Trends Study Shows New Competitive Dynamics and Increasing Reimbursement Hurdles 2Biotech Market Trends Study Shows New Competitive Dynamics and Increasing Reimbursement Hurdles 3Biotech Market Trends Study Shows New Competitive Dynamics and Increasing Reimbursement Hurdles 4HeartWare to Present at the Oppenheimer 22nd Annual Healthcare Conference 2
(Date:5/7/2015)... May 07, 2015 Centurion Service ... is proud to announce the upcoming live auction to ... surgery centers and other medical facilities from around the ... including radiology, surgery, endoscopy, lab, anesthesia, infusion, exam and ... Tuesday, May 12 starting at 9:00am PDT. The equipment ...
(Date:5/7/2015)... May 07, 2015 More than most public ... With constant media attention personal issues become public affairs and ... SCI TV , industry expert Katharine Nohr ... profile athletes Justin Gatlin and Michael Phelps. , With a ... her to start her own company, Nohr Sports Risk Management. ...
(Date:5/7/2015)... Wisconsin (PRWEB) May 07, 2015 When people ... give more consideration to their roofs than their basements. However, ... for flooding in crawlspaces and basements. While flooding is an ... to keep crawlspaces and unfinished areas dry to avoid a ... of a Damp Basement, Even small amounts of water can ...
(Date:5/7/2015)... (PRWEB) May 07, 2015 Aureus Medical ... travel nursing jobs and a variety of ... has released an infographic spotlighting top theme parks ... is aimed at thrill-seeking mobile healthcare professionals who are ... Travel healthcare careers offer an opportunity for the travel ...
(Date:5/7/2015)... 07, 2015 Dynamic Path, a leader ... its new free Alcohol Safety Exam Prep module ... restaurant managers, professional bartenders, and any front-of-house staff who ... Certification. The material encompasses topics taught in the National ... students can take the ServSafe Alcohol Proctored Exam or ...
Breaking Medicine News(10 mins):Health News:Centurion to Sell Surplus Medical Equipment in Online and On-site Auction 2Health News:Katharine Nohr Discusses Risk Management in Sports on SCI TV 2Health News:Katharine Nohr Discusses Risk Management in Sports on SCI TV 3Health News:Spring Storms Bring Musty Smell Inside 2Health News:Spring Storms Bring Musty Smell Inside 3Health News:Get to Know the Top Theme Parks: Aureus Medical Releases Infographic for the Travel Nurse and Other Travel Healthcare Professionals 2Health News:Dynamic Path Adds Alcohol Safety Exam Prep Module to Test Preparation Offerings 2
... between ages 15 and 45. When a tumor is found, ... way it's removed, which often leaves men infertile, //can change ... all men who have testicular tumors in one testicle will ... they will have no hormonproduction and no possibility for fertility. ...
... fight another. Researchers say the little-known virus GBV-C, also ... a key to helping researchers devise new strategies against ... Multicenter Acquired Immunodeficiency Syndrome Cohort Study, in which investigators ... United States for more than 15 years. The study ...
... fluids may do more harm than good for patients ... previous studies to determine if recommending patients with respiratory ... shown during a respiratory infection, such as a cold ... specific hormone that conserves water. Thus, researchers say giving ...
... errors that occur in pediatric intensive care units are more ... more than 11,800 children who were admitted into pediatric intensive ... defined an error as any preventable event that may cause ... were reported during the course of the study. Nearly 70 ...
... can no longer be considered a benign condition or ... 60 percent of overweight children have at least one ... type 2 diabetes is increasing rapidly in developing countries ... 2 diabetes in developing countries has been attributed to ...
... or other painkillers that is characterized by the onset ... after taking the medications. British researchers analyzed more than ... percent of adults and about 5 percent of children ... these patients were also sensitive to over-the-counter non-steroidal anti-inflammatory ...
Cached Medicine News:Health News:Childhood Weight Gain Found To Increase The Risk of Diabetes 2
200 L, Racked, Pre-sterilized, 96 tips/rack, clear Recommended for 20, 25, 50, 100 and 200 L pipettes. Can also be used with 300 L pipettes when pipetting 200 L or less....
... optimize the accuracy and precision of Finnpipettes. ... widely recognized by customers throughout the world. ... the years and now covers a full ... filter tips, certified pure tips, stepper tips ...
MBP's 200 L large orifice tip is perfect for handling fragile cells, viscous samples and genomic....
Designed to fit the Brinkmann Tranferpette and Treff Multi-Channel 300 L Pipettors, this tip provides extra space for repeat pipetting....
Medicine Products: